Title:
【発明の名称】免疫応答を導き出す抗原を同定するための組成物および方法
Document Type and Number:
Japanese Patent JP2003528573
Kind Code:
A
Abstract:
This invention relates to an expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, and a polynucleotide polyadenylation sequence all operatively linked. More particularly, it relates to the method of eliciting an immune response directed against an antigen in a mammal comprising the steps of introducing the expression vector into a cell, expressing the vector to produce an antigen under conditions wherein the antigen is secreted from the cell, endocytosing the secreted antigen into the cell, processing the antigen, and presenting fragments to a receptor to elicit a T-cell response. In addition, this invention relates to a vaccine and a method of use. The invention also relates to the method of identifying MHC-II restricted epitopes.
Inventors:
Chien, shi
You, Tuao Young
You, Tuao Young
Application Number:
JP2000616786A
Publication Date:
September 30, 2003
Filing Date:
May 05, 2000
Export Citation:
Assignee:
Wake Forest University
International Classes:
C12N15/09; A61K35/76; A61K39/00; A61K39/29; A61K47/48; A61K48/00; A61P1/04; A61P3/10; A61P19/02; A61P25/00; A61P29/00; A61P31/04; A61P31/10; A61P31/12; A61P35/00; A61P37/06; C07K14/005; C07K14/02; C07K14/195; C07K14/54; C07K14/73; C07K19/00; C12N1/19; C12N1/21; C12N5/08; C12N5/10; C12N15/867; C12Q1/68; A61K38/00; C12Q1/70; (IPC1-7): C12N15/09; A61K35/76; A61K39/00; A61K48/00; A61P1/04; A61P3/10; A61P19/02; A61P25/00; A61P29/00; A61P31/04; A61P31/10; A61P31/12; A61P35/00; A61P37/06; C07K14/005; C07K14/195; C07K14/54; C07K14/73; C07K19/00; C12N1/19; C12N1/21; C12N5/10; C12Q1/68
Domestic Patent References:
| JP2002507881A | 2002-03-12 | |||
| JPH08508252A | 1996-09-03 | |||
| JPH03503760A | 1991-08-22 | |||
| JPH10509702A | 1998-09-22 | |||
| JPH11503607A | 1999-03-30 | |||
| JP2002507881A | 2002-03-12 |
Other References:
JPN6010039442, Ａｒｃｈ． Ｐｈａｒｍ． Ｒｅｓ．, 1998, ｖｏｌ．２１ ｎｏ．５, ｐｐ．５３７−５４２
JPN6010039443, Ｐｒｏｃ． Ｎａｔｌ． Ａｃａｄ． Ｓｃｉ． ＵＳＡ, 1995, ｖｏｌ．９２, ｐｐ．７５７０−７５７４
JPN6010039444, ＢＩＯＴＥＣＨＮＯＬＯＧＹ, 1995, ｖｏｌ．１３, ｐｐ．１０７９−１０８４
JPN6010039440, Ｉｍｍｕｎｏｌ． Ｃｅｌｌ Ｂｉｏｌ．, 1990, ｖｏｌ．６８, ｐｐ．１１３−１１７
JPN6010039441, Ｐｒｏｃ． Ｎａｔｌ． Ａｃａｄ． Ｓｃｉ． ＵＳＡ, 1995, ｖｏｌ．９２, ｐｐ．９７４７−９７５１
JPN6010039443, Ｐｒｏｃ． Ｎａｔｌ． Ａｃａｄ． Ｓｃｉ． ＵＳＡ, 1995, ｖｏｌ．９２, ｐｐ．７５７０−７５７４
JPN6010039444, ＢＩＯＴＥＣＨＮＯＬＯＧＹ, 1995, ｖｏｌ．１３, ｐｐ．１０７９−１０８４
JPN6010039440, Ｉｍｍｕｎｏｌ． Ｃｅｌｌ Ｂｉｏｌ．, 1990, ｖｏｌ．６８, ｐｐ．１１３−１１７
JPN6010039441, Ｐｒｏｃ． Ｎａｔｌ． Ａｃａｄ． Ｓｃｉ． ＵＳＡ, 1995, ｖｏｌ．９２, ｐｐ．９７４７−９７５１
Attorney, Agent or Firm:
Heiyoshi Odashima